Insights

Gathering insights about EnGeneIC…

Similar companies to EnGeneIC

EnGeneIC Tech Stack

EnGeneIC uses 8 technology products and services including Twemoji, JSON-LD, jQuery Migrate, and more. Explore EnGeneIC's tech stack below.

Twemoji
Font Scripts
JSON-LD
Javascript Frameworks
jQuery Migrate
Javascript Libraries
X-XSS-Protection
Security
Bootstrap
UI Frameworks
HTTP/3
Web & Portal Technology
X-Content-Type-Options
Web & Portal Technology
Apache
Web Servers

Media & News

EnGeneIC Ltd launches australian trial for innovative cancer therapy.
EnGeneIC launches groundbreaking new australian trial for innovative cancer therapy, with international trial site in singapore to follow.
May 12, 2025 | www.tmcnet.com
SAM Holdings Corporation partners with EnGeneIC Ltd.
Under the partnership, SAM Holdings will collaborate with EnGeneIC on a profit-sharing basis for manufacturing and distribution of anti-cancer products based on the latter's proprietary technology platform, EnGeneIC Dream Vector (EDV).
Jun 09, 2024 | sg.finance.yahoo.com
EnGeneIC Ltd partners with Singapore Institute of Advanced Medicine Holdings Pte Ltd.
EnGeneIC, an Australia-based clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy, has announced strategic partnerships with Singapore Institute of Advanced Medicine Holdings (SAM) and Singapore Medical Incorporation (SMI).
Jun 07, 2024 | www.biospectrumasia.com
EnGeneIC Ltd received financing of $5M in pre-IPO round on Jan 1st '22.
Biotech startup EnGeneIC, has raised $5 million on the VentureCrowd platform in a pre-IPO round, ahead of plans for a NASDAQ listing in Q2 2022.
Dec 05, 2021 | www.pharmacyitk.com.au
EnGeneIC Ltd partners with ImmunityBio, Inc..
Australian company EnGeneIC has announced a landmark deal with major US biotech ImmunityBio, over a ground-breaking approach to both a COVID-19 vaccine and cancer treatment.
Nov 30, 2021 | www.yahoo.com
EnGeneIC Ltd is developing nanocellular Covid-19 vaccine.
Australian biotech tech company EnGeneIC is developing a potential new nanocellular Covid-19 vaccine.
Oct 20, 2021 | www.news.com.au
EnGeneIC Ltd recognized as most innovative company in the category of healthcare for 2019.
EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targeted cyto-immunotherapy in cancer, was named the most innovative company in the category of healthcare for 2019 by The Australian Financial Review in its 8 th annual AFR BOSS Most Innovative Companies list.
Aug 07, 2019 | www.prnewswire.com

EnGeneIC's Email Address Formats

EnGeneIC uses at least 1 format(s):

EnGeneIC Email Formats	Example	Percentage
FLast@engeneic.com	JDoe@engeneic.com	49%
First.Last@engeneic.com	John.Doe@engeneic.com	1%
FMiddleLast@engeneic.com	JMichaelDoe@engeneic.com	1%
FLast@engeneic.com	JDoe@engeneic.com	49%

Frequently Asked Questions

Where is EnGeneIC's headquarters located?

EnGeneIC's main headquarters is located at 11 Julius Avenue Level 4 North Ryde, New South Wales Australia. The company has employees across 2 continents, including OceaniaNorth America.

What is EnGeneIC's official website and social media links?

EnGeneIC's official website is engeneic.com and has social profiles on LinkedIn.

What is EnGeneIC's SIC code NAICS code?

EnGeneIC's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does EnGeneIC have currently?

As of February 2026, EnGeneIC has approximately 50 employees across 2 continents, including OceaniaNorth America. Key team members include Chief Financial Officer: B. H.Vice President Business Operations: S. P.Joint-Ceo And Director: J. M.. Explore EnGeneIC's employee directory with LeadIQ.

What industry does EnGeneIC belong to?

EnGeneIC operates in the Biotechnology Research industry.

What technology does EnGeneIC use?

EnGeneIC's tech stack includes TwemojiJSON-LDjQuery MigrateX-XSS-ProtectionBootstrapHTTP/3X-Content-Type-OptionsApache.

What is EnGeneIC's email format?

EnGeneIC's email format typically follows the pattern of FLast@engeneic.com. Find more EnGeneIC email formats with LeadIQ.

How much funding has EnGeneIC raised to date?

As of February 2026, EnGeneIC has raised $10M in funding. .

When was EnGeneIC founded?

EnGeneIC was founded in 2001.

EnGeneIC

Q: What is EnGeneIC's official website and social media links?

EnGeneIC's official website is engeneic.com. EnGeneIC has social profiles on LinkedIn.

Q: How many employees does EnGeneIC have currently?

EnGeneIC has approximately 50 employees.

Q: What technology does EnGeneIC use?

EnGeneIC's tech stack includes Cloudflare, Font Awesome, jQuery Migrate, Apache HTTP Server, HSTS.

Biotechnology ResearchNew South Wales, Australia11-50 Employees

EngeneIC is a biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform.

Company Overview

Headquarters: 11 Julius Avenue Level 4 North Ryde, New South Wales Australia
Website: engeneic.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2001
Employees: 11-50

Media & News

Funding & Financials

$10M
EnGeneIC has raised a total of $10M of funding over 1 rounds. .
$1M$10M
EnGeneIC's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$10M
EnGeneIC has raised a total of $10M of funding over 1 rounds. .
$1M$10M
EnGeneIC's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to EnGeneIC

AsclepiX Therapeutics

AnaptysBio

Cardurion Pharmaceuticals

Alector

argenx

Annexon Biosciences

ImmuNext

Abpro

EnGeneIC Tech Stack

Media & News

EnGeneIC Ltd launches australian trial for innovative cancer therapy.

SAM Holdings Corporation partners with EnGeneIC Ltd.

EnGeneIC Ltd partners with Singapore Institute of Advanced Medicine Holdings Pte Ltd.

EnGeneIC Ltd received financing of $5M in pre-IPO round on Jan 1st '22.

EnGeneIC Ltd partners with ImmunityBio, Inc..

EnGeneIC Ltd is developing nanocellular Covid-19 vaccine.

EnGeneIC Ltd recognized as most innovative company in the category of healthcare for 2019.

EnGeneIC's Email Address Formats

Frequently Asked Questions

Where is EnGeneIC's headquarters located?

What is EnGeneIC's official website and social media links?

What is EnGeneIC's SIC code NAICS code?

How many employees does EnGeneIC have currently?

What industry does EnGeneIC belong to?

What technology does EnGeneIC use?

What is EnGeneIC's email format?

How much funding has EnGeneIC raised to date?

When was EnGeneIC founded?

EnGeneIC

Company Overview

Media & News

EnGeneIC Ltd launches australian trial for innovative cancer therapy.

SAM Holdings Corporation partners with EnGeneIC Ltd.

EnGeneIC Ltd partners with Singapore Institute of Advanced Medicine Holdings Pte Ltd.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?